Sofinnova Investments as of March 31, 2020
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 64 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Karuna Therapeutics Ord | 12.6 | $136M | 1.9M | 72.00 | |
Ascendis Pharma A S (ASND) | 11.6 | $125M | 1.1M | 112.61 | |
Nextcure (NXTC) | 9.2 | $99M | 2.7M | 37.07 | |
Natera (NTRA) | 8.6 | $93M | 3.1M | 29.86 | |
Principia Biopharma | 7.8 | $84M | 1.4M | 59.38 | |
Y Mabs Therapeutics (YMAB) | 5.3 | $57M | 2.2M | 26.10 | |
Merck & Co (MRK) | 3.3 | $36M | 464k | 76.94 | |
Coherus Biosciences (CHRS) | 2.9 | $31M | 1.9M | 16.22 | |
Galera Therapeutics (GRTX) | 2.7 | $29M | 3.1M | 9.50 | |
Alexion Pharmaceuticals | 2.6 | $28M | 307k | 89.79 | |
Merus N V (MRUS) | 2.2 | $24M | 2.0M | 12.10 | |
United Therapeutics Corporation (UTHR) | 2.0 | $22M | 234k | 94.82 | |
Amarin Corporation (AMRN) | 1.9 | $21M | 5.2M | 4.00 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.9 | $20M | 86k | 237.96 | |
BioMarin Pharmaceutical (BMRN) | 1.9 | $20M | 240k | 84.50 | |
Biogen Idec (BIIB) | 1.5 | $17M | 53k | 316.36 | |
Acceleron Pharma | 1.4 | $15M | 165k | 89.87 | |
Kiniksa Pharmaceuticals (KNSA) | 1.3 | $14M | 923k | 15.48 | |
Nucana Biomed ordinary shares | 1.3 | $14M | 2.4M | 5.83 | |
Nucana Plc american depositary shares (NCNA) | 1.2 | $13M | 2.3M | 5.83 | |
Ptc Therapeutics I (PTCT) | 1.2 | $13M | 292k | 44.61 | |
Obseva Sa | 1.1 | $11M | 4.7M | 2.41 | |
Sarepta Therapeutics (SRPT) | 0.9 | $9.9M | 102k | 97.81 | |
Kala Pharmaceuticals | 0.9 | $9.8M | 1.1M | 8.79 | |
Myokardia | 0.8 | $8.2M | 175k | 46.87 | |
Align Technology (ALGN) | 0.7 | $8.1M | 47k | 173.95 | |
Gilead Sciences Inc option | 0.7 | $7.5M | 100k | 74.75 | |
Kala Pharmaceuticals Inc put | 0.6 | $6.5M | 737k | 8.79 | |
Kadmon Hldgs | 0.6 | $6.4M | 1.5M | 4.19 | |
Chiasma | 0.6 | $5.9M | 1.6M | 3.65 | |
Mirum Pharmaceuticals (MIRM) | 0.5 | $5.9M | 419k | 14.00 | |
Heron Therapeutics (HRTX) | 0.5 | $5.7M | 482k | 11.74 | |
Puma Biotechnology (PBYI) | 0.5 | $5.4M | 638k | 8.44 | |
Amicus Therapeutics (FOLD) | 0.4 | $4.9M | 526k | 9.24 | |
Iterum Therapeutics | 0.4 | $4.7M | 1.7M | 2.71 | |
Iovance Biotherapeutics Inc call | 0.4 | $4.5M | 150k | 29.94 | |
Axsome Therapeutics (AXSM) | 0.4 | $4.3M | 73k | 58.82 | |
Abbvie (ABBV) | 0.4 | $3.8M | 50k | 76.22 | |
Blueprint Medicines (BPMC) | 0.3 | $3.7M | 63k | 58.46 | |
Calithera Biosciences | 0.3 | $3.6M | 819k | 4.44 | |
Homology Medicines | 0.3 | $3.6M | 231k | 15.54 | |
Applied Genetic Technol Corp C | 0.3 | $3.5M | 1.1M | 3.28 | |
Akero Therapeutics Inc put | 0.3 | $3.2M | 150k | 21.19 | |
Akero Therapeutics (AKRO) | 0.3 | $3.1M | 148k | 21.20 | |
Entasis Therapeutics Holdings Ord | 0.3 | $3.1M | 1.2M | 2.64 | |
Otonomy | 0.3 | $3.0M | 1.5M | 1.97 | |
ALNYLAM PHARMACEUTICALS INC. Common Stock cmn | 0.3 | $2.9M | 27k | 108.83 | |
Tg Therapeutics (TGTX) | 0.3 | $2.7M | 275k | 9.84 | |
Chemocentryx | 0.2 | $2.7M | 67k | 40.18 | |
Rigel Pharmaceuticals (RIGL) | 0.2 | $2.3M | 1.4M | 1.56 | |
Ptc Therapeutics | 0.2 | $2.2M | 50k | 44.60 | |
Compugen (CGEN) | 0.2 | $2.2M | 300k | 7.26 | |
Sage Therapeutics (SAGE) | 0.2 | $2.1M | 74k | 28.73 | |
Aclaris Therapeutics (ACRS) | 0.2 | $2.0M | 1.9M | 1.04 | |
Zymeworks | 0.2 | $1.8M | 50k | 35.49 | |
BioCryst Pharmaceuticals (BCRX) | 0.2 | $1.6M | 816k | 2.00 | |
Menlo Therapeutics | 0.1 | $1.6M | 605k | 2.68 | |
Apellis Pharmaceuticals (APLS) | 0.1 | $1.3M | 50k | 26.79 | |
Mersana Therapeutics (MRSN) | 0.1 | $1.3M | 225k | 5.83 | |
Synlogic | 0.1 | $989k | 575k | 1.72 | |
Zogenix | 0.1 | $816k | 33k | 24.74 | |
Fate Therapeutics (FATE) | 0.1 | $811k | 37k | 22.19 | |
Intra Cellular Therapies (ITCI) | 0.1 | $799k | 52k | 15.36 | |
Pds Biotechnology Ord (PDSB) | 0.0 | $104k | 143k | 0.73 |